Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-23
DOI
10.1038/s41388-018-0575-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- KLF10 loss in the pancreas provokes activation of SDF-1 and induces distant metastases of pancreatic ductal adenocarcinoma in the KrasG12D p53flox/flox model
- (2017) C-C Weng et al. ONCOGENE
- Pancreatic Tumor Progression Associated With CD133 Overexpression
- (2016) Ching-Chieh Weng et al. PANCREAS
- Cancer Stem Cell Marker Phenotypes Are Reversible and Functionally Homogeneous in a Preclinical Model of Pancreatic Cancer
- (2015) Joseph S. Dosch et al. CANCER RESEARCH
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity
- (2012) Himisha Beltran et al. EUROPEAN UROLOGY
- CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated
- (2012) J. B. Overdevest et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells
- (2011) Ji-Won Lee et al. Journal of Natural Medicines
- Combined point mutations in codon 12 and 13 of KRAS oncogene in prostate carcinomas
- (2011) Fatma Silan et al. MOLECULAR BIOLOGY REPORTS
- Bone metastasis in prostate cancer: emerging therapeutic strategies
- (2011) Justin Sturge et al. Nature Reviews Clinical Oncology
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- (2010) Georgia Hatzivassiliou et al. NATURE
- CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
- (2010) M-Q Gao et al. ONCOGENE
- Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases
- (2010) Nanda K. Thudi et al. PROSTATE
- PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers
- (2009) S. Wee et al. CANCER RESEARCH
- CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery
- (2009) X.-R. Yang et al. CLINICAL CANCER RESEARCH
- Claudin-7 Regulates EpCAM-Mediated Functions in Tumor Progression
- (2009) T. Nubel et al. MOLECULAR CANCER RESEARCH
- Nuclear signalling by tumour-associated antigen EpCAM
- (2009) Dorothea Maetzel et al. NATURE CELL BIOLOGY
- Targeting CD24 for Treatment of Colorectal and Pancreatic Cancer by Monoclonal Antibodies or Small Interfering RNA
- (2008) E. Sagiv et al. CANCER RESEARCH
- Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms
- (2008) J. Dai et al. CANCER RESEARCH
- BRAF Activation Initiates but Does Not Maintain Invasive Prostate Adenocarcinoma
- (2008) Joseph H. Jeong et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now